CHICAGO, Sept. 16, 2020 /PRNewswire/ — EVERSANA™, the main supplier of world industrial providers to the life sciences trade, as we speak launched ACTICS by EVERSANA™, the technology-enabled resolution to optimize end-to-end industrial success for all times science corporations. Combining the ability of AI-driven predictive analytics with ready-to-deploy, real-time industrial providers, ACTICS offers the cloud-based resolution pharmaceutical innovators have to optimize actions within the product and affected person journeys.
Leveraging proprietary and built-in knowledge, ACTICS is constructed on a data-mastering platform and cloud-based infrastructure, enabling the power to mix a number of knowledge sources right into a complete and actionable system. Through API-driven automated intelligence and machine studying expertise, ACTICS feeds downstream alerts to extra cloud-based infrastructure, comparable to a consumer’s CRM system, to create actionable insights.
Further complemented by wrap-around knowledge science providers and subscription-based choices, shoppers can energy their industrial success via the whole ACTICS resolution, which, when paired with EVERSANA’s built-in industrial providers, will combine and analyze all knowledge factors after which set off and affect real-time actions to drive worth throughout the care continuum.
“EVERSANA now delivers on the full promise of real-time intelligence driving next best actions across the therapeutic and patient journeys,” stated Brigham Hyde, president, Data & Analytics, EVERSANA. “We’ve made the aggressive investments in technology, data and people to activate data-driven engagement to advance access and adherence at each stage of the product life cycle.”
As a scalable resolution, ACTICS may clear up particular industrial challenges, comparable to optimizing market entry, proof creation or patient-finding limitations. Clients can leverage choose ACTICS capabilities, together with project-based knowledge science providers, knowledge accessibility and platform licenses for subscription-based modules and platform functions.
Development of the ACTICS resolution was expedited after EVERSANA’s acquisition of HVH Precision Analytics and its predictive analytics platform in July 2020. ACTICS is being leveraged into the launch and commercialization methods for a number of pharmaceutical and digital therapies and works seamlessly with EVERSANA’s built-in industrial providers platform designed to resolve world pricing, entry, reimbursement, real-world proof, adherence and product supply challenges within the life science sector.
“This marks a transformative moment for next-generation commercial services. No other service provider has the data and analytics platform paired with fully integrated commercial services to trigger, optimize and measure value for clients, their portfolios and their patients,” stated Jim Lang, CEO, EVERSANA.
For extra data, go to eversana.com.
EVERSANA™ is the main unbiased supplier of world providers to the life sciences trade. The firm’s built-in options are rooted within the affected person expertise and span all levels of the product life cycle to ship long-term, sustainable worth for sufferers, prescribers, channel companions and payers. The firm serves greater than 500 organizations, together with progressive start-ups and established pharmaceutical corporations, to advance life science options for a more healthy world. To be taught extra about EVERSANA, go to eversana.com or join via LinkedIn and Twitter.